LabCorp Launches Test for Coronavirus Disease 2019 (COVID-19)

The LabCorp 2019 Novel Coronavirus (COVID-19), NAA Test is for Use by Clinicians with Patients Who Meet COVID-19 Evaluation Criteria BURLINGTON, N.C. --(BUSINESS WIRE)-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, is making its

LabCorp Is Scheduled to Present at the 2020 Barclays Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)-- LabCorp® (NYSE: LH) today announced that members of the executive management team will participate in a fireside chat at the Barclays Global Healthcare Conference in Miami Beach on Tuesday, March 10 at 8:30 a.m. ET .